Spatial Analysis of Common Gastrointestinal Tract Cancers in Counties of Iran

  • Soleimani, Ali (Department of Epidemiology, Research Center for Health Sciences, School of Health, Shiraz University of Medical Science) ;
  • Hassanzadeh, Jafar (Department of Epidemiology, Research Center for Health Sciences, School of Health, Shiraz University of Medical Science) ;
  • Motlagh, Ali Ghanbari (Non-Communicable Diseases, Deputy of Health, Ministry of Health and Medical Education-Cancer Research Center, Shahid Beheshti University of Medical Sciences) ;
  • Tabatabaee, Hamidreza (Department of Epidemiology, Research Center for Health Sciences, School of Health, Shiraz University of Medical Science) ;
  • Partovipour, Elham (Non-Communicable Diseases, Deputy of Health, Ministry of Health and Medical Education) ;
  • Keshavarzi, Sareh (Department of Epidemiology, Research Center for Health Sciences, School of Health, Shiraz University of Medical Science) ;
  • Hossein, Mohammad (Department of Epidemiology, Research Center for Health Sciences, School of Health, Shiraz University of Medical Science)
  • Published : 2015.05.18


Background: Gastrointestinal tract cancers are among the most common cancers in Iran and comprise approximately 38% of all the reported cases of cancer. This study aimed to describe the epidemiology and to investigate spatial clustering of common cancers of the gastrointestinal tract across the counties of Iran using full Bayesian smoothing and Moran I Index statistics. Materials and Methods: The data of the national registry cancer were used in this study. Besides, indirect standardized rates were calculated for 371 counties of Iranand smoothed using Winbug 1.4 software with a full Bayesian method. Global Moran I and local Moran I were also used to investigate clustering. Results: According to the results, 75,644 new cases of cancer were nationally registered in Iran among which 18,019 cases (23.8%) were esophagus, gastric, colorectal, and liver cancers. The results of Global Moran's I test were 0.60 (P=0.001), 0.47 (P=0.001), 0.29 (P=0.001), and 0.40 (P=0.001) for esophagus, gastric, colorectal, and liver cancers, respectively. This shows clustering of the four studied cancers in Iran at the national level. Conclusions: High level clustering of the cases was seen in northern, northwestern, western, and northeastern areas for esophagus, gastric, and colorectal cancers. Considering liver cancer, high clustering was observed in some counties in central, northeastern, and southern areas.


  1. Abdullayev R, Kracalik I, Ismayilova R, et al (2012). Analyzing the spatial and temporal distribution of human brucellosis in Azerbaijan (1995-2009) using spatial and spatio-temporal statistics. BMC infectious diseases, 12, 10.
  2. Ahmad OB, Boschi-Pinto C, Lopez AD, et al (2001). Age standardization of rates: a new WHO standard, World Health Organization Geneva.
  3. Ansari R, Mahdavinia M, Sadjadi A, et al (2006). Incidence and age distribution of colorectal cancer in Iran: results of a population-based cancer registry. Cancer Letters, 240, 143-7.
  4. Anselin L (1994). Exploratory spatial data analysis and geographic information systems. New tools for spatial analysis, 54.
  5. Anselin L (1999). Interactive techniques and exploratory spatial data analysis. Geographical Information Systems: Principles, Techniques, Management and Applications, eds.
  6. Anselin L, Getis A (2010). Spatial statistical analysis and geographic information systems. In 'Perspectives on Spatial Data Analysis', Eds Springer, 35-47
  7. Asmarian NS, Kavousi A, Salehi M (2013a). Mapping of large intestine cancer incidence rate using area-to-area poisson kriging in Iran from 2003 to 2007. Razi J MedSci, 20, 7.
  8. Asmarian NS, Ruzitalab A, Amir K, et al (2013b). Area-to-area poisson kriging analysis of mapping of county-level esophageal cancer incidence rates in Iran. Asian Pac J Cancer Prev, 14, 3.
  9. Atrkar-Roushan Z, Kazemnejad A, Mansour-Ghanaei F, et al (2013). Trend analysis of gastrointestinal cancer incidences in Guilan province: comparing rates over 15 years. Asian Pac J Cancer Prev, 14, 7587-93.
  10. Banerjee S, Carlin BP, Gelfand AE (2014). Hierarchical modeling and analysis for spatial data, Crc Press.
  11. Bernard W, Christopher P (2014). World cancer report 2014. international agency for research on cancer. World Health Organization, Lyon, France.
  12. Bernardinelli L, Montomoli C (1992). Empirical Bayes versus fully Bayesian analysis of geographical variation in disease risk. Stat Med, 11, 983-1007.
  13. Besag J, York J, Mollie A (1991). Bayesian image restoration, with two applications in spatial statistics. Ann Institute Statist Math, 43, 19.
  14. Best N, Richardson S, Thomson A (2005). A comparison of Bayesian spatial models for disease mapping. Stat Methods Med Res, 14, 35-59.
  15. Cancer IAfRo (2009). Cancer incidence in five continents, international agency for research on cancer. [DETAIL]
  16. Center MM, Jemal A, Ward E (2009). International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomarkers Prev, 18, 1688-94
  17. Clayton D, Kaldor J (1987). Empirical Bayes estimates of age-standardized relative risks for use in disease mapping. Biometrics, [ISSUE] 671-81
  18. Doll SR (1980). The epidemiology of cancer. Cancer, 45, 2475-85.<2475::AID-CNCR2820451004>3.0.CO;2-6
  19. Gomaa AI, Khan SA, Toledano MB, et al (2008). Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis. World J Gastroenterol, 14, 4300.
  20. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA: Cancer J Clin, 61, 69-90.
  21. Kavousi A, Bashiri Y, Mehrabi Y, et al (2014). Identifying high-risk clusters of gastric cancer incidence in iran, 2004-2009. Asian Pac J Cancer Prev, 15, 10335-7.
  22. Lawson A, Biggeri A, Boehning D, et al (2000). Disease mapping models: an empirical evaluation. Disease Mapping Collaborative Group. Statist Med, 19, 2217-41.<2217::AID-SIM565>3.0.CO;2-E
  23. Lawson AB, Browne WJ, Rodeiro CLV (2003). Disease mapping with WinBUGS and MLwiN, John Wiley & Sons.
  24. Malekzadeh R, Derakhshan MH, Malekzadeh Z (2009). Gastric cancer in Iran: epidemiology and risk factors. Arch Iran Med, 12, 576-83.
  25. Moghaddam SD, Haghdoost AA, Hoseini SH, et al (2010). Incidence of hepatocellular carcinoma in southeast iran. Hepat Mon, 10, 270.
  26. Moghimi-Dehkordi B, Safaee A, Zali MR (2008). Prognostic factors in 1,138 Iranian colorectal cancer patients. Intern J Colorectal Dis, 23, 683-8.
  27. Mohebbi M, Mahmoodi M, Wolfe R, et al (2008). Geographical spread of gastrointestinal tract cancer incidence in the Caspian Sea region of Iran: spatial analysis of cancer registry data. BMC Cancer, 8, 137.
  28. Mousavi SM, Gouya MM, Ramazani R, et al (2009). Cancer incidence and mortality in Iran. Ann Oncol, 20, 556-63.
  29. Parkin DM, Bray F, Ferlay J, et al (2005). Global cancer statistics, 2002. CA: Cancer J Clin, 55, 74-108.
  30. Plummer M, Best N, Cowles K, et al (2006). CODA: Convergence diagnosis and output analysis for MCMC. R News, 6, 7-11.
  31. Radmard AR (2010). Five common cancers in Iran. Arch Iran Med, 13, 143-6.
  32. Rytkonen MJP (2004). Not all maps are equal: GIS and spatial analysis in epidemiology. Intern J Circumpolar Health, 63.
  33. Sadjadi A, Malekzadeh R, Derakhshan MH, et al (2003). Cancer occurrence in Ardabil: Results of a population-based Cancer Registry from Iran. Int J Cancer, 107, 113-8.
  34. Sadjadi A, Marjani H, Semnani S, et al (2010). Esophageal cancer in Iran: A review. Middle East J Cancer, 1, 5-14.
  35. Semnani S, Sadjadi A, Fahimi S, et al (2006). Declining incidence of esophageal cancer in the Turkmen Plain, eastern part of the Caspian Littoral of Iran: a retrospective cancer surveillance. Cancer Detect Prev, 30, 14-9
  36. Somi MH, Golzari M, Farhang S, et al (2014). Gastrointestinal cancer incidence in East Azerbaijan, Iran: update on 5 year incidence and trends. Asian Pac J Cancer Prev, 15, 3945-9.
  37. Spiegelhalter D, Thomas A, Best N, et al (2004). WinBUGS User Manual version 1.4 January 2003 MRC Biostatistics Unit. Inst. of Public Health, Cambridge, England.
  38. Wakefield J (2007). Disease mapping and spatial regression with count data. Biostatistics, 8, 158-83.
  39. Yazdanbod A, Nasseri-Moghaddam S, Malekzadeh R (2004). Upper gastrointestinal cancer in Ardabil, North West of Iran: A review. Arch Iranian Med, 7, 173-7.
  40. Zhang J, Yin F, Zhang T, et al (2014). Spatial analysis on human brucellosis incidence in mainland China: 2004-2010. BMJ open, 4.

Cited by

  1. Bayesian spatio-temporal analysis of stomach cancer incidence in Iran, 2003–2010 vol.32, pp.10, 2018,
  2. Spatial analysis of reported new cases and local risk of leprosy in hyper-endemic situation in Northeastern Brazil vol.23, pp.7, 2018,